Matthews International Capital Management LLC Taro Pharmaceutical Industries LTD Transaction History

Matthews International Capital Management LLC

$589 Million
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$97.82 - $116.09 $14.1 Million - $16.8 Million	-144,612 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$97.62 - $120.59 $24.3 Million - $30 Million	-248,488 Reduced 63.21%	144,612 $16.7 Million
Q1 2018 May 10, 2018	SELL	$95.91 - $107.26 $5.22 Million - $5.83 Million	-54,400 Reduced 12.16%	393,100 $38.8 Million
Q4 2017 Feb 12, 2018	SELL	$104.5 - $126.38 $21.6 Million - $26.1 Million	-206,700 Reduced 31.6%	447,500 $46.9 Million
Q3 2017 Nov 13, 2017	SELL	$97.26 - $116.2 $14.7 Million - $17.6 Million	-151,600 Reduced 18.81%	654,200 $73.7 Million
Q2 2017 Aug 11, 2017	BUY	N/A	805,800	805,800 $90.3 Million

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matthews International Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matthews International Capital Management LLC with notifications on news.

Account